{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:03:09Z","timestamp":1778893389906,"version":"3.51.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1038\/ni0901-810","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:43:54Z","timestamp":1027673034000},"page":"810-815","source":"Crossref","is-referenced-by-count":35,"title":["Tolerogenic strategies to halt or prevent type 1 diabetes"],"prefix":"10.1038","volume":"2","author":[{"given":"Anne","family":"Cooke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny M.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M.","family":"Parish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFni0901810_CR1","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.4049\/jimmunol.159.7.3109","volume":"159","author":"CE Egwuagu","year":"1997","unstructured":"Egwuagu, C. E., Charukamnoetkanok, P. & Gery, I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J. Immunol. 159, 3109\u20133131 (1997).","journal-title":"J. Immunol."},{"key":"BFni0901810_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S0952-7915(98)80085-X","volume":"10","author":"D Hanahan","year":"1998","unstructured":"Hanahan, D. Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity. Curr. Opin. Immunol. 10, 656\u2013662 (1998).","journal-title":"Curr. Opin. Immunol."},{"key":"BFni0901810_CR3","first-page":"199","volume":"63","author":"NM Parish","year":"1988","unstructured":"Parish, N. M., Rayner, D., Cooke, A. & Roitt, I. M. An investigation of the nature of induced suppression to experimental autoimmune thyroiditis. Immunology 63, 199\u2013203 (1988).","journal-title":"Immunology"},{"key":"BFni0901810_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/0008-8749(88)90305-X","volume":"112","author":"DM Bitar","year":"1988","unstructured":"Bitar, D. M. & Whitacre, C. C. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immunol. 112, 364\u2013370 (1988).","journal-title":"Cell. Immunol."},{"key":"BFni0901810_CR5","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.4049\/jimmunol.164.11.5771","volume":"164","author":"PS Heeger","year":"2000","unstructured":"Heeger, P. S. et al. Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant. J. Immunol. 164, 5771\u20135781 (2000).","journal-title":"J. Immunol."},{"key":"BFni0901810_CR6","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/eji.1830240926","volume":"24","author":"A al-Sabbagh","year":"1994","unstructured":"al-Sabbagh, A., Miller, A., Santos, L. M. & Weiner, H. L. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein- induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur. J. Immunol. 24, 2104\u20132109 (1994).","journal-title":"Eur. J. Immunol."},{"key":"BFni0901810_CR7","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/intimm\/5.9.1159","volume":"5","author":"BW Metzler","year":"1993","unstructured":"Metzler, B. W. & Wraith, D.C. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5, 1159\u20131165 (1993).","journal-title":"Int. Immunol."},{"key":"BFni0901810_CR8","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.4049\/jimmunol.164.12.6366","volume":"164","author":"GG Burrows","year":"2000","unstructured":"Burrows, G. G. et al. Regulation of encephalitogenic T cells with recombinant TCR ligands. J. Immunol. 164, 6366\u20136371 (2000).","journal-title":"J. Immunol."},{"key":"BFni0901810_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.19.1.225","volume":"19","author":"B Salomon","year":"2001","unstructured":"Salomon, B. & Bluestone, J. A. Complexities of CD28\/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19, 225\u2013252 (2001).","journal-title":"Annu. Rev. Immunol."},{"key":"BFni0901810_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2337\/diab.32.3.247","volume":"32","author":"S Kataoka","year":"1983","unstructured":"Kataoka, S. et al. Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes 32, 247\u2013253 (1983).","journal-title":"Diabetes"},{"key":"BFni0901810_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF00429781","volume":"14","author":"AF Nakhooda","year":"1978","unstructured":"Nakhooda, A. F., Like, A. A., Chappel, C. I., Wei, C. N. & Marliss, E. B. The spontaneously diabetic Wistar rat (the \u201cBB\u201d rat). Studies prior to and during development of the overt syndrome. Diabetologia 14, 199\u2013207 (1978).","journal-title":"Diabetologia"},{"key":"BFni0901810_CR12","first-page":"219","volume":"45","author":"JA Todd","year":"1997","unstructured":"Todd, J. A. Genetics of type 1 diabetes. Pathol. Biol. Paris 45, 219\u2013227 (1997).","journal-title":"Pathol. Biol. Paris"},{"key":"BFni0901810_CR13","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/eji.1830210512","volume":"21","author":"LA O'Reilly","year":"1991","unstructured":"O'Reilly, L. A. et al. Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur. J. Immunol. 21, 1171\u20131180 (1991).","journal-title":"Eur. J. Immunol."},{"key":"BFni0901810_CR14","first-page":"622","volume":"60","author":"A Miyazaki","year":"1985","unstructured":"Miyazaki, A. et al. Predominance of T lymphocytes in pancreatic islets and spleen of pre- diabetic non-obese diabetic (NOD) mice: a longitudinal study. Clin. Exp. Immunol. 60, 622\u2013630 (1985).","journal-title":"Clin. Exp. Immunol."},{"key":"BFni0901810_CR15","first-page":"132","volume":"53","author":"RK Sibley","year":"1985","unstructured":"Sibley, R. K., Sutherland, D. E., Goetz, F. & Michael, A. F. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab. Invest. 53, 132\u2013144 (1985).","journal-title":"Lab. Invest."},{"key":"BFni0901810_CR16","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2337\/diab.34.11.1205","volume":"34","author":"IL Campbell","year":"1985","unstructured":"Campbell, I. L., Wong, G. H., Schrader, J. W. & Harrison, L. C. Interferon-\u03b3 enhances the expression of the major histocompatibility class I antigens on mouse pancreatic \u03b2 cells. Diabetes 34, 1205\u20131209 (1985).","journal-title":"Diabetes"},{"key":"BFni0901810_CR17","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1084\/jem.180.3.995","volume":"180","author":"XD Yang","year":"1994","unstructured":"Yang, X. D. et al. Effect of tumor necrosis factor \u03b1 on insulin-dependent diabetes mellitus in NOD mice. 1. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180, 995\u20131004 (1994).","journal-title":"J. Exp. Med."},{"key":"BFni0901810_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2337\/diab.36.5.641","volume":"36","author":"T Mandrup-Poulsen","year":"1987","unstructured":"Mandrup-Poulsen, T. et al. Islet cytotoxicity of interleukin 1. Influence of culture conditions and islet donor characteristics. Diabetes 36, 641\u2013647 (1987).","journal-title":"Diabetes"},{"key":"BFni0901810_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1096\/fasebj.7.2.8440413","volume":"7","author":"JA Corbett","year":"1993","unstructured":"Corbett, J. A., Sweetland, M. A., Lancaster, J. R. Jr & McDaniel, M. L. A 1-hour pulse with IL-1 \u03b2 induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism. FASEB J. 7, 369\u2013374 (1993).","journal-title":"FASEB J."},{"key":"BFni0901810_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/jaut.1997.0184","volume":"11","author":"P Hutchings","year":"1998","unstructured":"Hutchings, P. & Cooke, A. Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration. J. Autoimmun. 11, 127\u2013130 (1998).","journal-title":"J. Autoimmun."},{"key":"BFni0901810_CR21","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4049\/jimmunol.163.3.1178","volume":"163","author":"R Tisch","year":"1999","unstructured":"Tisch, R., Wang, B. & Serreze, D. V. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. J. Immunol. 163, 1178\u20131187 (1999).","journal-title":"J. Immunol."},{"key":"BFni0901810_CR22","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/nm1296-1348","volume":"2","author":"J Tian","year":"1996","unstructured":"Tian, J. et al. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nature Med. 2, 1348\u20131353 (1996).","journal-title":"Nature Med."},{"key":"BFni0901810_CR23","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1073\/pnas.93.2.956","volume":"93","author":"D Daniel","year":"1996","unstructured":"Daniel, D. & Wegmann, D. R. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl Acad. Sci. USA 93, 956\u2013960 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFni0901810_CR24","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2337\/diab.39.8.933","volume":"39","author":"MA Atkinson","year":"1990","unstructured":"Atkinson, M. A., Maclaren, N. K. & Luchetta, R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39, 933\u2013937 (1990).","journal-title":"Diabetes"},{"key":"BFni0901810_CR25","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1084\/jem.183.4.1561","volume":"183","author":"J Tian","year":"1996","unstructured":"Tian, J. et al. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183, 1561\u20131567 (1996).","journal-title":"J. Exp. Med."},{"key":"BFni0901810_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S1074-7613(00)80121-1","volume":"11","author":"D Homann","year":"1999","unstructured":"Homann, D. et al. Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4\/Stat6 pathway. Immunity 11, 463\u2013472 (1999).","journal-title":"Immunity"},{"key":"BFni0901810_CR27","doi-asserted-by":"crossref","unstructured":"Ehl, S. et al. Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J. Exp. Med. 187, 763-774 (1998).","DOI":"10.1084\/jem.187.5.763"},{"key":"BFni0901810_CR28","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1073\/pnas.89.8.3434","volume":"89","author":"T Maki","year":"1992","unstructured":"Maki, T., Ichikawa, T., Blanco, R. & Porter, J. Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. Proc. Natl Acad. Sci. USA 89, 3434\u20133438 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFni0901810_CR29","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/eji.1830220735","volume":"22","author":"P Hutchings","year":"1992","unstructured":"Hutchings, P., O'Reilly, L., Parish, N. M., Waldmann, H. & Cooke, A. The use of a non-depleting anti-CD4 monoclonal antibody to re-establish tolerance to \u03b2 cells in NOD mice. Eur. J. Immunol. 22, 1913\u20131918 (1992).","journal-title":"Eur. J. Immunol."},{"key":"BFni0901810_CR30","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1002\/eji.1830260815","volume":"26","author":"B Wang","year":"1996","unstructured":"Wang, B., Gonzalez, A., Benoist, C. & Mathis, D. The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol. 26, 1762\u20131769 (1996).","journal-title":"Eur. J. Immunol."},{"key":"BFni0901810_CR31","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4362::AID-IMMU4362>3.0.CO;2-2","volume":"28","author":"NM Parish","year":"1998","unstructured":"Parish, N. M., Bowie, L., Zusman Harach, S., Phillips, J. M. & Cooke, A. Thymus-dependent monoclonal antibody-induced protection from transferred diabetes. Eur. J. Immunol. 28, 4362\u20134373 (1998).","journal-title":"Eur. J. Immunol."},{"key":"BFni0901810_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1073\/pnas.91.1.123","volume":"91","author":"L Chatenoud","year":"1994","unstructured":"Chatenoud, L., Thervet, E., Primo, J. & Bach, J. F. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl Acad. Sci. USA 91, 123\u2013127 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFni0901810_CR33","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1073\/pnas.82.19.6627","volume":"82","author":"C Boitard","year":"1985","unstructured":"Boitard, C. et al. In vivo prevention of thyroid and pancreatic autoimmunity in the BB rat by antibody to class II major histocompatibility complex gene products. Proc. Natl Acad. Sci. USA 82, 6627\u20136631 (1985).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFni0901810_CR34","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/eji.1830210511","volume":"21","author":"P Sempe","year":"1991","unstructured":"Sempe, P. et al. Anti-\u03b1\/\u03b2 T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. Eur. J. Immunol. 21, 1163\u20131169 (1991).","journal-title":"Eur. J. Immunol."},{"key":"BFni0901810_CR35","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2337\/diab.40.9.1203","volume":"40","author":"T Taki","year":"1991","unstructured":"Taki, T. et al. Prevention of cyclophosphamide-induced and spontaneous diabetes in NOD\/Shi\/Kbe mice by anti-MHC class I Kd monoclonal antibody. Diabetes 40, 1203\u20131209 (1991).","journal-title":"Diabetes"},{"key":"BFni0901810_CR36","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s001090050342","volume":"77","author":"B Kuttler","year":"1999","unstructured":"Kuttler, B., Rosing, K., Lehmann, M., Brock, J. & Hahn, H. J. Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies. J. Mol. Med. 77, 226\u2013229 (1999).","journal-title":"J. Mol. Med."},{"key":"BFni0901810_CR37","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1172\/JCI119762","volume":"100","author":"GA Arreaza","year":"1997","unstructured":"Arreaza, G. A. et al. Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism. J. Clin. Invest. 100, 2243\u20132253 (1997).","journal-title":"J. Clin. Invest."},{"key":"BFni0901810_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2337\/diabetes.50.2.270","volume":"50","author":"RD Molano","year":"2001","unstructured":"Molano, R. D. et al. Prolonged islet graft survival in NOD mice by blockade of the CD40- CD154 pathway of T-cell costimulation. Diabetes 50, 270\u2013276 (2001).","journal-title":"Diabetes"},{"key":"BFni0901810_CR39","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.4049\/jimmunol.165.4.1949","volume":"165","author":"JM Phillips","year":"2000","unstructured":"Phillips, J. M. et al. Nondepleting anti-CD4 has an immediate action on diabetogenic effector cells, halting their destruction of pancreatic \u03b2 cells. J. Immunol. 165, 1949\u20131955 (2000).","journal-title":"J. Immunol."},{"key":"BFni0901810_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/08916939309008856","volume":"15","author":"P Hutchings","year":"1993","unstructured":"Hutchings, P. et al. The regulation of autoimmunity through CD4+ T cells. Autoimmunity 15, 21\u201323 (1993).","journal-title":"Autoimmunity"},{"key":"BFni0901810_CR41","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1126\/science.8094901","volume":"259","author":"S Qin","year":"1993","unstructured":"Qin, S. et al. \u201cInfectious\u201d transplantation tolerance. Science 259, 974\u2013977 (1993).","journal-title":"Science"},{"key":"BFni0901810_CR42","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0952-7915(98)80217-3","volume":"10","author":"S Cobbold","year":"1998","unstructured":"Cobbold, S. & Waldmann, H. Infectious tolerance. Curr. Opin. Immunol. 10, 518\u2013524 (1998).","journal-title":"Curr. Opin. Immunol."},{"key":"BFni0901810_CR43","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1097\/00007890-200106150-00027","volume":"71","author":"Z Guo","year":"2001","unstructured":"Guo, Z. et al. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection. Transplantation 71, 1656\u20131665 (2001).","journal-title":"Transplantation"},{"key":"BFni0901810_CR44","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.4049\/jimmunol.158.6.2947","volume":"158","author":"L Chatenoud","year":"1997","unstructured":"Chatenoud, L., Primo, J. & Bach, J. F. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J. Immunol. 158, 2947\u20132954 (1997).","journal-title":"J. Immunol."},{"key":"BFni0901810_CR45","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/00007890-199004000-00009","volume":"49","author":"L Chatenoud","year":"1990","unstructured":"Chatenoud, L. et al. In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids. Transplantation 49, 697\u2013702 (1990).","journal-title":"Transplantation"},{"key":"BFni0901810_CR46","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/00007890-199909150-00003","volume":"68","author":"ES Woodle","year":"1999","unstructured":"Woodle, E. S. et al. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3\u03b31(Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation 68, 608\u2013616 (1999).","journal-title":"Transplantation"},{"key":"BFni0901810_CR47","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1097\/00007890-199912150-00005","volume":"68","author":"PJ Friend","year":"1999","unstructured":"Friend, P. J. et al. Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection. Transplantation 68, 1632\u20131637 (1999).","journal-title":"Transplantation"},{"key":"BFni0901810_CR48","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","volume":"19","author":"M Feldmann","year":"2001","unstructured":"Feldmann, M. & Maini, R. N. Anti-TNF-\u03b1 therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 19, 163\u2013196 (2001).","journal-title":"Annu. Rev. Immunol."},{"key":"BFni0901810_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0168-8227(90)90017-N","volume":"8","author":"M Harada","year":"1990","unstructured":"Harada, M., Kishimoto, Y. & Makino, S. Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diab. Res. Clin. Pract. 8, 85\u201389 (1990).","journal-title":"Diab. Res. Clin. Pract."},{"key":"BFni0901810_CR50","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1046\/j.1365-2249.1999.00781.x","volume":"115","author":"TC Martins","year":"1999","unstructured":"Martins, T. C. & Aguas, A. P. Mechanisms of Mycobacterium avium-induced resistance against insulin- dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice: role of Fas and Th1 cells. Clin. Exp. Immunol. 115, 248\u2013254 (1999).","journal-title":"Clin. Exp. Immunol."},{"key":"BFni0901810_CR51","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1073\/pnas.88.8.3088","volume":"88","author":"D Elias","year":"1991","unstructured":"Elias, D. et al. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl Acad. Sci. USA 88, 3088\u20133091 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFni0901810_CR52","doi-asserted-by":"publisher","first-page":"6148","DOI":"10.4049\/jimmunol.165.11.6148","volume":"165","author":"FJ Quintana","year":"2000","unstructured":"Quintana, F. J., Rotem, A., Carmi, P. & Cohen, I. R. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity. J. Immunol. 165, 6148\u20136155 (2000).","journal-title":"J. Immunol."},{"key":"BFni0901810_CR53","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4049\/jimmunol.164.2.558","volume":"164","author":"K Ohashi","year":"2000","unstructured":"Ohashi, K., Burkart, V., Flohe, S. & Kolb, H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 164, 558\u2013561 (2000).","journal-title":"J. Immunol."},{"key":"BFni0901810_CR54","doi-asserted-by":"crossref","unstructured":"Vabulas, R. M. et al. Endocytosed heat shock protein 60s use TLR2 and TLR4 to activate the toll\/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. Published online 11 June 2001 as 10.1074\/jbc.M103217200.","DOI":"10.1074\/jbc.M103217200"},{"key":"BFni0901810_CR55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1046\/j.1365-3024.1999.00213.x","volume":"21","author":"A Cooke","year":"1999","unstructured":"Cooke, A. et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 21, 169\u2013176 (1999).","journal-title":"Parasite Immunol."},{"key":"BFni0901810_CR56","first-page":"465","volume":"7","author":"FGB Banting","year":"1922","unstructured":"Banting, F. G. B. & Best, C. H. The internal secretion of the pancreas. J. Lab. Clin. Med. 7, 465\u2013480 (1922).","journal-title":"J. Lab. Clin. Med."},{"key":"BFni0901810_CR57","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM200007273430401","volume":"343","author":"AM Shapiro","year":"2000","unstructured":"Shapiro, A. M. et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230\u2013238 (2000).","journal-title":"N. Engl. J. Med."},{"key":"BFni0901810_CR58","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s001250051636","volume":"44","author":"B Soria","year":"2001","unstructured":"Soria, B., Skoudy, A. & Martin, F. From stem cells to \u03b2 cells: new strategies in cell therapy of diabetes mellitus. Diabetologia 44, 407\u2013415 (2001).","journal-title":"Diabetologia"},{"key":"BFni0901810_CR59","first-page":"25","volume-title":"Handbook of Physiology","author":"RL Pictet","year":"1972","unstructured":"Pictet, R. L. & Rutter, W. J. in Handbook of Physiology (eds. Steiner, D. & Freinkel, N.) 25\u201366 (Williams and Wilkins, Baltimore, MD, 1972)."},{"key":"BFni0901810_CR60","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1172\/JCI114574","volume":"85","author":"GC Weir","year":"1990","unstructured":"Weir, G. C. & Bonner-Weir, S. Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes. J. Clin. Invest. 85, 983\u2013987 (1990).","journal-title":"J. Clin. Invest."},{"key":"BFni0901810_CR61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1242\/dev.118.1.33","volume":"118","author":"D Gu","year":"1993","unstructured":"Gu, D. & Sarvetnick, N. Epithelial cell proliferation and islet neogenesis in IFN-\u03b3 transgenic mice. Development 118, 33\u201346 (1993).","journal-title":"Development"},{"key":"BFni0901810_CR62","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/73128","volume":"6","author":"VK Ramiya","year":"2000","unstructured":"Ramiya, V. K. et al. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nature Med. 6, 278\u2013282 (2000).","journal-title":"Nature Med."},{"key":"BFni0901810_CR63","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1073\/pnas.97.14.7999","volume":"97","author":"S Bonner\u2013Weir","year":"2000","unstructured":"Bonner\u2013Weir, S. et al. In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl Acad. Sci. USA 97, 7999\u20138004 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFni0901810_CR64","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2337\/diab.46.4.599","volume":"46","author":"LA O'Reilly","year":"1997","unstructured":"O'Reilly, L. A. et al. \u03b1-Cell neogenesis in an animal model of IDDM. Diabetes 46, 599\u2013606 (1997).","journal-title":"Diabetes"},{"key":"BFni0901810_CR65","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/371606a0","volume":"371","author":"J Jonsson","year":"1994","unstructured":"Jonsson, J., Carlsson, L., Edlund, T. & Edlund, H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371, 606\u2013609 (1994).","journal-title":"Nature"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ni0901-810.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni0901-810","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni0901-810.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:31:38Z","timestamp":1684449098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni0901-810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["BFni0901810"],"URL":"https:\/\/doi.org\/10.1038\/ni0901-810","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}